Pharmaceutical Business Investment Opportunities

Company based in Calgary, Alberta focused on the manufacturing and sales of radiology imaging drugs, with a specific emphasis on barium contrast drugs used by both private and government healthcare facilities in the radiology industry, currently in the pre-revenue stage. - The company is in the process of developing iodine drugs and creating new endohedral fullerene drugs from captured CO2, targeting a market valued at $6.5 billion. - With plans to commence operations this year, the company emphasizes the strategic importance of critical minerals required for the creation of radiology drugs, and it possesses its own resources, enabling it to vertically integrate its radiology drug business. - Aspiring to become the first vertically-integrated North American supplier of medical imaging contrast agents, the company is focused on producing a line of generic and new innovative barium and iodine radiology imaging contrast media products. Additionally, involved in the development of a new carbon fullerene drug for magnetic resonance imaging (MRI). - These products will be supplied to healthcare and imaging facilities. The first contract was signed for USD 1.9M. - Business has 5 Health Canada drug licenses, partnership and exclusive rights to develop endohedral fullerene drugs for the radiology imaging market, and a carbon capture program for future carbon revenue generation.

The company is a pharmaceutical marketing firm based in Bhagalpur, focusing on oral care and skincare products, with plans to commence sales from the next month. - The company has a diverse portfolio comprising 4 pharmaceutical brands, 2 hair care brands, and 2 skincare brands. - The directors of the company collectively possess over 25 years of extensive experience in the healthcare industry, ensuring a strong foundation for the business. - The company has established partnerships with two third-party manufacturers located in Yamuna Nagar and Surat to facilitate production and supply of its products. - Initial market targeting will be focused on the Bihar region, with plans for potential expansion into other regions as the business grows. - The company is in the process of finalizing its drug license, which is expected to be completed within the next two weeks, enabling the commencement of product sales. - The company has secured agreements with approximately 10-15 doctors for the distribution and promotion of its products, laying the groundwork for a robust sales network. - With a primary emphasis on oral care products such as mouthwash, the company is poised to capitalize on the growing demand for oral hygiene solutions in the market.

An online marketplace based in Brazil, focused on medicinal cannabis products. - Connects consumers and healthcare professionals to various brands and retailers offering a diverse range of products such as edibles, topicals, and extracts. - The marketplace provides a database of treatments and medical conditions, along with user reviews, to educate consumers about the products and their effects, aiming to ensure informed purchasing decisions. - The business ensures that all brands and retailers listed on the platform comply with the standards established by Anvisa, the Brazilian Health Regulatory Agency. - With a customer base of over 50,000 and more than 12 manufacturers/brands/resellers from Europe and USA listed and 800+ direct-selling distributors the marketplace has seen substantial growth, averaging over 13,000 monthly organic website visits. - The business's revenue model involves sellers paying the platform a commission ranging from 15% to 30% on each product sold, with the average order value being USD 120. - The marketplace aims to assist retailers in structuring their marketing and ordering tools to remain compliant while also protecting and educating consumers about the products available for purchase. - The business prides itself on providing a curated selection of the best brands, catering to various experiences and price ranges, aiming to offer the best value to its customers. - There are 12 permanent employees and additionally, there are resellers who work on a contract basis. - The promoter is based in Spain but the business is registered and operating from Brazil.

The company is a pan-India organization with a vision of achieving INR 100 crores turnover in the next 5 years, reflecting its ambitious growth plans in the Pharma Marketing industry. - The company's portfolio includes brands in the pediatric neurology and pediatric gastroenterology segments, focused on providing innovative clinical nutrition products. Currently, the sales team is actively engaged in meeting super specialist doctors across the country to promote these products. - With a presence in Aurangabad, the company operates from a rental office and has a godown at Kalher, Bhiwandi, and warehouses spread across the country from Srinagar to Kanyakumari, demonstrating its extensive distribution network. - The company has established tie-ups with over 100 stockists/distributors in various regions, showcasing a well-connected supply chain network. - Over the last 10 months, the company has successfully engaged more than 300 doctors who are prescribing its brands, indicating a positive reception of its products within the medical community. - The owner brings 13 years of industry experience and has a significant achievement of being the first CEO in 105 years to speak at the ICMR from a non-medical background, underscoring his expertise and leadership in the field. - We started operations in July last year and are looking to complete our first entire calendar year of operations this year. - We have all the required certifications to function.

Albanian-based essential oil distillery that specializes in the production of high-quality, organic essential oils using native plants found in the Albanian flora. - We are committed to preserving and promoting the rich botanical heritage of Albania by sustainably sourcing our raw materials and using traditional distillation methods to extract the purest essential oils. - Our team of experts is dedicated to ensuring that our oils are of the highest quality and potency, and we are proud to offer a wide range of natural and pure essential oils that are perfect for use in aromatherapy, personal care, and wellness products. - The production capacity of the unit is 200 liters monthly. - As a supplier we are committed to offering competitive prices and building long-lasting relationships with our customers by providing exceptional service and quality. - We are looking to start the production once we get the investment.

A company with well-established products having a presence in 5+ districts of Orissa with a strong distribution network covering more than 50 doctors with a team of well-trained medical representatives. - 1 product is under trademark registration. - We are selling around 7 products. - The products are certified by ISO and backed by an experienced team of skilled Pharma professionals and a quality research team. - We have been in the industry for over 16 years as a trusted name in the Pharmaceutical Industry.

Business focused on developing a portfolio of supervision-free medications for pets. - The current product is a long-acting injectable designed to control pain in dogs with bone cancer. - This product can also be prescribed off-label for other painful conditions in pets. - The company plans to expand this drug delivery system to treat other conditions. - The drug delivery platform is based on technology originally developed for humans, and the CEO was part of the development team. - The company’s goal is to remove the burden of dosing, ensure adherence to prescriptions, and provide greater comfort to sick pets. - Formulation, manufacturing and marketing is all outsourced. - The company has developed prototypes of their products but is yet to conduct clinical trials and obtain FDA licensing. - The business model is business-to-business (B2B), with plans to sell directly to veterinarians.

1. Established firm: The company has a strong establishment, having been in the industry for 14 years, demonstrating stability and experience in the pharma marketing sector. 2. Wide client base: With over 250 clients, the company has a well-established customer base, indicating a strong market presence and potential for sustained revenue streams. 3. Niche Market Focus: The company specializes in marketing analgesic products to doctors and chemists, indicating a specific focus within the pharmaceutical marketing sector. 4. Growth Potential: With a relatively small team of 3 employees, there is potential for scalability and expansion, presenting an opportunity for investors to participate in the company's growth trajectory. 5. License: Drug License and GST Certificate.

Pharmaceutical marketing firm operating in the eye care segment, headquartered in Mumbai, India. - The company has a total of 21+ products, with its top-selling products being tears eye drops, and antioxidant tablets. - The revenue model is based on marketing products to ophthalmologists, with patient sourcing through retailers upon prescription. - The company has a substantial market presence, meeting with 2000+ ophthalmologists every month and generating a ARR of 2.5 crore. - Operates with a business-to-business model, distributing its products through 50+ distributors in Mumbai, Maharashtra & Goa who in turn supply to pharma retailers, resulting in an average of 60 to 70 orders per week. - The manufacturing of products is outsourced to two manufacturers under the company's own brand. - The promoter of the company has 15 years of experience in the pharmaceutical industry. - Business has a Drug License.